Zhongmou Therapeutics
Clinical trials sponsored by Zhongmou Therapeutics, explained in plain language.
-
First-in-Human trial tests gene therapy for blinding eye disease
Disease control Recruiting nowThis is the first study in people to test the safety and early effects of an experimental gene therapy called ZM-02 for retinitis pigmentosa (RP), an inherited disease that causes progressive vision loss. About 12 adults with RP will receive either a single injection of the thera…
Phase: EARLY_PHASE1 • Sponsor: Zhongmou Therapeutics • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New test could help people with severe vision loss see colors better
Knowledge-focused Recruiting nowThis study aims to understand how color vision loss progresses in people with inherited retinal diseases. Researchers will observe about 200 participants to see how changes in the retina relate to color vision problems. They will also test a new color vision test designed specifi…
Sponsor: Zhongmou Therapeutics • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:38 UTC